To evaluate the effect of SHOC2 inhibition in vivo in an autochthonous lung cancer model we used the LSL-KrasG12D model, alone (K model) or in combination with a LSL-Trp53R172H allele (KP model) that develops a more severe phenotype compared to the K model36,37. This evidence concerns the gene SHOC2 and lung cancer.